Literature DB >> 7940424

Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis.

Y Dai1, T P Dean, M K Church, J O Warner, J K Shute.   

Abstract

BACKGROUND: Inflammation associated with neutrophil infiltration is a commonly observed feature of children with cystic fibrosis. Production of the major neutrophil chemotactic cytokine interleukin 8 (IL-8) is potentially of great importance in the pathology of cystic fibrosis. Concentrations of IL-8 in both sputum and bronchoalveolar lavage fluid have been found to be higher in children with cystic fibrosis than in controls. The IL-8 induced chemotactic response and numbers of IL-8 receptors on peripheral neutrophils obtained from children with cystic fibrosis have been compared with a control group of children.
METHODS: Cells were isolated from 18 patients with cystic fibrosis (aged 4-20 years) and 13 controls (aged 5-12 years) by dextran centrifugation followed by separation on Lymphoprep. Chemotaxis was assayed using multiwell microchemotaxis chambers and 5 microns polycarbonate filters. Filters were fixed and stained with Haema-Gurr for counting. Results were expressed as numbers of neutrophils per high power field (HPF).
RESULTS: At the optimum concentration (1 x 10(-8) mol/l) the number of cells migrating were similar for controls (150 (12)/HPF) and for the cystic fibrosis group (140 (14)/HPF)). At lower concentrations the numbers of neutrophils migrating were lower for the cystic fibrosis group. Scatchard analysis of 125I-labelled IL-8 binding revealed lower numbers of receptors on neutrophils from patients with cystic fibrosis (22,000 per cell) than from controls (75,000 per cell).
CONCLUSIONS: Reduced responsiveness to IL-8 of neutrophils from patients with cystic fibrosis is associated with receptor desensitisation as a result of exposure to high systemic levels of IL-8.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940424      PMCID: PMC475175          DOI: 10.1136/thx.49.9.867

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 2.  Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium.

Authors:  P N Devreotes; S H Zigmond
Journal:  Annu Rev Cell Biol       Date:  1988

3.  Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils.

Authors:  A K Samanta; J J Oppenheim; K Matsushima
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

4.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung.

Authors:  S L Kunkel; T Standiford; K Kasahara; R M Strieter
Journal:  Exp Lung Res       Date:  1991 Jan-Feb       Impact factor: 2.459

5.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung.

Authors:  T J Standiford; S L Kunkel; M A Basha; S W Chensue; J P Lynch; G B Toews; J Westwick; R M Strieter
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.

Authors:  J A Rankin; I Sylvester; S Smith; T Yoshimura; E J Leonard
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8.

Authors:  P M Grob; E David; T C Warren; R P DeLeon; P R Farina; C A Homon
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

8.  Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis.

Authors:  T P Dean; Y Dai; J K Shute; M K Church; J O Warner
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

9.  Identification of different charged species of a human monocyte derived neutrophil activating peptide (MONAP).

Authors:  J M Schröder; U Mrowietz; E Christophers
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

10.  Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

Authors:  J M Schröder; E Christophers
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

View more
  10 in total

1.  Abnormalities in the pulmonary innate immune system in cystic fibrosis.

Authors:  Theo J Moraes; Jonathan Plumb; Raiza Martin; Eric Vachon; Vera Cherepanov; Adeline Koh; Carola Loeve; Jenny Jongstra-Bilen; Joanna H Zurawska; Julianne V Kus; Lori L Burrows; Sergio Grinstein; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-17       Impact factor: 6.914

Review 2.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

3.  Bronchoalveolar lavage in children with inflammatory and non inflammatory lung disease.

Authors:  D Gidaris; F Kanakoudi-Tsakalidou; D Papakosta; V Tzimouli; A Taparkou; M Ventouri; I Tsanakas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 4.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

5.  Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin.

Authors:  S Brennan; D Cooper; P D Sly
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

6.  Altered cytokine production by cystic fibrosis tracheal gland serous cells.

Authors:  W Kammouni; C Figarella; S Marchand; M Merten
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients.

Authors:  C Hubeau; R Le Naour; M Abély; J Hinnrasky; M Guenounou; D Gaillard; E Puchelle
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.

Authors:  Robert L Young; Kenneth C Malcolm; Jennifer E Kret; Silvia M Caceres; Katie R Poch; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Scott H Randell; Michael L Vasil; Jane L Burns; Samuel M Moskowitz; Jerry A Nick
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 9.  CFTR activity and mitochondrial function.

Authors:  Angel Gabriel Valdivieso; Tomás A Santa-Coloma
Journal:  Redox Biol       Date:  2013-02-05       Impact factor: 11.799

10.  The Antimicrobial Activity of Peripheral Blood Neutrophils Is Altered in Patients with Primary Ciliary Dyskinesia.

Authors:  Maaike Cockx; Marfa Blanter; Mieke Gouwy; Pieter Ruytinx; Sara Abouelasrar Salama; Sofie Knoops; Noëmie Pörtner; Lotte Vanbrabant; Natalie Lorent; Mieke Boon; Sofie Struyf
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.